loadpatents
name:-0.055819034576416
name:-0.032202959060669
name:-0.0041098594665527
Blanche; Francis Patent Filings

Blanche; Francis

Patent Applications and Registrations

Patent applications and USPTO patent grants for Blanche; Francis.The latest application filed is for "anti-ceacam5 antibodies and uses thereof".

Company Profile
3.34.47
  • Blanche; Francis - Paris FR
  • Blanche; Francis - 75019 Paris FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Anti-CEACAM5 antibodies and uses thereof
Grant 11,332,542 - Berne , et al. May 17, 2
2022-05-17
Anti-ceacam5 Antibodies And Uses Thereof
App 20200102401 - BERNE; Pierre-Francois ;   et al.
2020-04-02
Anti-CEACAM5 antibodies and uses thereof
Grant 10,457,739 - Berne , et al. Oc
2019-10-29
Humanized Antibodies Specific To The Protofibrillar Form Of The Beta-amyloid Peptide
App 20190119365 - Baurin; Nicolas ;   et al.
2019-04-25
Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
Grant 10,112,991 - Baurin , et al. October 30, 2
2018-10-30
Anti-lamp1 Antibodies And Antibody Drug Conjugates, And Uses Thereof
App 20180142032 - BAUDAT; Yves ;   et al.
2018-05-24
Anti-ceacam5 Antibodies And Uses Thereof
App 20180022817 - BERNE; Pierre-Francois ;   et al.
2018-01-25
Anti-LAMP1 antibodies and antibody drug conjugates, and uses thereof
Grant 9,809,653 - Baudat , et al. November 7, 2
2017-11-07
Anti-CEACAM5 antibodies and uses thereof
Grant 9,617,345 - Berne , et al. April 11, 2
2017-04-11
Humanized Antibodies Specific To The Protofibrillar Form Of The Beta-amyloid Peptide
App 20160368977 - Baurin; Nicolas ;   et al.
2016-12-22
Robo1-Fc fusion protein and use thereof for treating tumours
Grant 9,493,529 - Blanche , et al. November 15, 2
2016-11-15
Anti-lamp1 Antibodies And Antibody Drug Conjugates, And Uses Thereof
App 20160280793 - BAUDAT; Yves ;   et al.
2016-09-29
Antagonist antibodies and their fab fragments against GPVI and uses thereof
Grant 9,441,040 - Baurin , et al. September 13, 2
2016-09-13
Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
Grant 9,382,312 - Baurin , et al. July 5, 2
2016-07-05
Anti-ceacam5 Antibodies And Uses Thereof
App 20160108131 - BERNE; Pierre-Francois ;   et al.
2016-04-21
Novel Antagonist Antibodies And Their Fab Fragments Against Gpvi And Uses Thereof
App 20150098939 - BAURIN; Nicolas ;   et al.
2015-04-09
Antagonist antibodies and their fab fragments against GPVI and uses thereof
Grant 8,852,593 - Baurin , et al. October 7, 2
2014-10-07
Humanized Antibodies Specific To The Protofibrillar Form Of The Beta-amyloid Peptide
App 20140105890 - BAURIN; Nicolas ;   et al.
2014-04-17
Method Of Production Of Sialylated Antibodies
App 20140046032 - Blanche; Francis ;   et al.
2014-02-13
Modified Soluble Fgf Receptor Fc Fusions Method
App 20140030265 - BLANCHE; Francis ;   et al.
2014-01-30
Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
Grant 8,614,299 - Baurin , et al. December 24, 2
2013-12-24
Modified soluble FGF receptor Fc fusions method
Grant 8,481,487 - Blanche , et al. July 9, 2
2013-07-09
Anti-gitr Antibodies
App 20130108641 - Baurin; Nicolas ;   et al.
2013-05-02
Purification of a triple helix formation with an immobilized obligonucleotide
Grant 8,399,636 - Crouzet , et al. March 19, 2
2013-03-19
Robo1-fc Fusion Protein And Use Thereof For Treating Tumours
App 20130039912 - Blanche; Francis ;   et al.
2013-02-14
Polypeptides For Binding To The Receptor For Advanced Glycation Endproducts As Well As Compositions And Methods Involving
App 20120282637 - Huber; Jochen ;   et al.
2012-11-08
Novel Antagonist Antibodies And Their Fab Fragments Against Gpvi And Uses Thereof
App 20120244152 - Baurin; Nicolas ;   et al.
2012-09-27
Modified Soluble Fgf Receptor Fc Fusions With Improved Biological Activity
App 20120195851 - BLANCHE; Francis ;   et al.
2012-08-02
Humanized Antibodies Specific To The Protofibrillar Form Of The Beta-amyloid Peptide
App 20120177639 - Baurin; Nicolas ;   et al.
2012-07-12
Modified soluble FGF receptor Fc fusions with improved biological activity
Grant 8,119,770 - Blanche , et al. February 21, 2
2012-02-21
Purification Of A Triple Helix Formation With An Immobilized Oligonucleotide
App 20110319605 - CROUZET; Joel ;   et al.
2011-12-29
Purification of a triple helix formation with an immobilized oligonucleotide
Grant 8,017,744 - Crouzet , et al. September 13, 2
2011-09-13
Fgf-r4 Receptor-specific Antagonists
App 20110150903 - Baurin; Nicolas ;   et al.
2011-06-23
Modified Soluble Fgf Receptor Fc Fusions Wsith Improved Biological Activity
App 20100061979 - Blanche; Francis ;   et al.
2010-03-11
Purification Of A Triple Helix Formation With An Immobilized Oligonucleotide
App 20100010208 - CROUZET; Joel ;   et al.
2010-01-14
Processes for purifying and for detecting target double-stranded DNA sequences by triple helix interaction
Grant 7,514,218 - Blanche , et al. April 7, 2
2009-04-07
Processes for purifying and for detecting target double-stranded DNA sequences by triple helix interaction
App 20080064031 - Blanche; Francis ;   et al.
2008-03-13
Method for purifying plasmid DNA
App 20070213289 - Blanche; Francis ;   et al.
2007-09-13
Method of preparation for pharmaceutical grade plasmid DNA
App 20070111221 - Blanche; Francis ;   et al.
2007-05-17
Composition intended for the preservation of infectious recombinant adenoviruses
Grant 7,202,078 - Blanche , et al. April 10, 2
2007-04-10
Processes for purifying and for detecting target double-stranded DNA sequences by triple helix interaction
App 20060205000 - Blanche; Francis ;   et al.
2006-09-14
Polypeptides involved in the biosynthesis of streptogramins, nucleotide sequences coding for these polypeptides and their use
Grant 7,090,999 - Blanc , et al. August 15, 2
2006-08-15
Processes for purifying and for detecting target double-stranded DNA sequences by triple helix interaction
Grant 7,052,838 - Blanche , et al. May 30, 2
2006-05-30
Purification of a triple heli formation with an immobilized oligonucleotide
Grant 7,038,026 - Crouzet , et al. May 2, 2
2006-05-02
Purification of a triple helix formation with an immobilized oligonucleotide
App 20060036085 - Crouzet; Joel ;   et al.
2006-02-16
Methods of increasing the production of cobalamins using cob gene expression
App 20060019352 - Blanche; Francis ;   et al.
2006-01-26
Method for producing recombinant adenovirus
App 20050287657 - Blanche, Francis ;   et al.
2005-12-29
Method for producing recombinant adenovirus
Grant 6,905,862 - Blanche , et al. June 14, 2
2005-06-14
Streptogramins and method for preparing same by mutasynthesis
Grant 6,833,382 - Blanc , et al. December 21, 2
2004-12-21
DNA molecules, preparation and use in gene therapy
Grant 6,825,012 - Blanche , et al. November 30, 2
2004-11-30
Polypeptides involved in the biosynthesis of streptogramins, nucleotide sequences coding for these polypeptides and their use
App 20040229236 - Blanc, Veronique ;   et al.
2004-11-18
Composition intended for the preservation of infectious recombinant adenoviruses
App 20040191909 - Blanche, Francis ;   et al.
2004-09-30
Composition intended for the preservation of infectious recombinant adenoviruses
Grant 6,734,008 - Blanche , et al. May 11, 2
2004-05-11
Novel topoisomerase IV, corresponding nucleotide sequences and uses thereof
App 20040077005 - Blanche, Francis ;   et al.
2004-04-22
Kringle polypeptides and methods for using them to inhibit angiogenesis
App 20040052777 - Nesbit, Mark ;   et al.
2004-03-18
Abrogen polypeptides, nucleic acids encoding them and methods for using them to inhibit angiogenesis
App 20040052810 - Nesbit, Mark ;   et al.
2004-03-18
Polypeptides involved in the biosynthesis of streptogramins, nucleotide sequences coding for these polypeptides and their use
Grant 6,670,157 - Blanc , et al. December 30, 2
2003-12-30
Methods of increasing the production of cobalamins using cob gene expression
Grant 6,656,709 - Blanche , et al. December 2, 2
2003-12-02
Topoisomerase IV, corresponding nucleotide sequences and uses thereof
Grant 6,649,394 - Blanche , et al. November 18, 2
2003-11-18
Purification of a triple heli formation with an immobilized oligonucleotide
App 20030186268 - Crouzet, Joel ;   et al.
2003-10-02
Method of separating viral particles
App 20030170710 - Blanche, Francis ;   et al.
2003-09-11
Processes for purifying and for detecting target double-stranded DNA sequences by triple helix interaction
App 20030165876 - Blanche, Francis ;   et al.
2003-09-04
Method for producing recombinant adenovirus
App 20030143730 - Blanche, Francis ;   et al.
2003-07-31
Method of separating viral particles
Grant 6,537,793 - Blanche , et al. March 25, 2
2003-03-25
DNA molecules, preparation and use in gene therapy
App 20030032092 - Blanche, Francis ;   et al.
2003-02-13
Method for producing recombinant adenovirus
Grant 6,485,958 - Blanche , et al. November 26, 2
2002-11-26
Streptogramins And Method For Preparing Same By Mutasynthesis
App 20020142947 - Blanc, Veronique ;   et al.
2002-10-03
Variants of thymidine kinase, related nucleic acids sequences and their use in genic therapy
App 20020102247 - Crouzet, Joel ;   et al.
2002-08-01
Composition intended for the preservation of infectious recombinant adenoviruses
App 20020061592 - Blanche, Francis ;   et al.
2002-05-23
Method of separating viral particles
App 20020037565 - Blanche, Francis ;   et al.
2002-03-28
Method For Producing Recombinant Adenovirus
App 20020028497 - BLANCHE, FRANCIS ;   et al.
2002-03-07
Pharmaceutical composition useful for nucleic acid transfection, and use thereof
Grant 6,153,597 - Blanche , et al. November 28, 2
2000-11-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed